Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets.

Clinical aspects of chondrosarcoma, gene dysregulation, mutation, histone modifications and non-coding RNAs associated with tumor development and therapeutic response modulation, targets for targeted therapies as a promising molecular therapeutic approach are summarized.